Amicus Therapeutics, Inc.
FOLD
$14.38
$0.010.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 51.68% | 86.57% | 68.13% | 80.03% | 62.99% |
| Total Depreciation and Amortization | -12.72% | -12.48% | -9.67% | -6.16% | 8.56% |
| Total Amortization of Deferred Charges | 13.62% | 13.18% | 2.51% | -5.77% | -13.53% |
| Total Other Non-Cash Items | -18.57% | -23.14% | -15.41% | -23.95% | -8.04% |
| Change in Net Operating Assets | 59.94% | -40.65% | -155.96% | -5.15% | -106.17% |
| Cash from Operations | 197.80% | 148.93% | -8.98% | 104.41% | 50.95% |
| Capital Expenditure | 7.23% | 34.25% | 47.48% | 73.27% | 52.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,541.23% | -6,649.37% | -701.74% | -150.88% | -97.16% |
| Cash from Investing | -8,191.43% | -1,362.55% | -840.69% | -159.06% | -100.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -180.41% | 99.98% | 99.99% | 99.98% | 99.98% |
| Issuance of Common Stock | -29.50% | -95.74% | -69.86% | -76.49% | -73.60% |
| Repurchase of Common Stock | 16.81% | 35.46% | 29.01% | 21.71% | -22.91% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -88.09% | -200.72% | -77.30% | -88.02% | -91.70% |
| Foreign Exchange rate Adjustments | 429.37% | 251.33% | 18.36% | -12.88% | -163.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.80% | -45.87% | -2,447.67% | -158.69% | -134.41% |